SwingBatter12

CASI PHARAMACUETICALS Inc 3-5 days Swing Trade

SwingBatter12 Mis à jour   
NASDAQ:CASI   CASI Pharmaceuticals, Inc.
Think this may double back to 6.6 for an entry and go to 7 at least. Think 3-5 day Swing Trade.

Target 1 $7 will most likely exit here as this is in a downtrend
Target 2 7.33
Commentaire:
retest possibly coming 6.6-6.62 may be good entry
Commentaire:
Market is selling off may watch out for that as well
Commentaire:
so close to my $7 mark i would watch closely as it may fly or sell off when its gets above that area. I will be taking some profits at 7.
Commentaire:
Took all profit im out of this position at 7.04
Commentaire:
Might get back in at 6.72 area will be watching that area for uptrend continuation
Commentaire:
added some more at 6.74 forming hihgher low. Swing for tommorow
Commentaire:
Around 4000 shares bought in after hours around 7. Possibly the price may start at around 7 again if that continues.
Commentaire:
people sold at resistance of 7.05 I'm letting this one ride move up my stop loss to 6.9
Commentaire:
Sold some here think this maybe next turning point
Commentaire:
6.83-6.86 is the range i would be looking at for next entry or trend change backup.
Commentaire:
Made around 20 percent of this one stock so fa.
Commentaire:
Getting to my entry price again will be watch the bid size
Commentaire:
Got in at 6.86 again for swing past 7.15. Bid support increasing at 6.88
Commentaire:
bullish engulfing on 3 min chart. Death star on 15 min chart. May start to move
Commentaire:
moving again some bot was hitting stop losses causing that bullish engulfing right around the ascending traingle test
Commentaire:
Revising this trade chart has drastically changed. Looking for a low entry tomorrow to swing for 6.87 probably about a 4% return.
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.